

Complete guide to Posaconazole drug interactions. Learn which medications are dangerous to combine, which need dose adjustments, and what to tell your doctor.
Posaconazole (brand name Noxafil) is a powerful antifungal medication — and a powerful inhibitor of a liver enzyme called CYP3A4. This enzyme is responsible for metabolizing a long list of common medications. When Posaconazole blocks CYP3A4, it can cause other drugs to build up to dangerously high levels in your body.
This isn't a minor concern. Some Posaconazole drug interactions are outright contraindicated — meaning the medications should never be used together. Others require careful dose adjustments and monitoring. Understanding these interactions is critical for your safety.
If you're new to Posaconazole, start with our overview of what Posaconazole is and how it's used.
To understand why Posaconazole interacts with so many medications, it helps to know the basics:
These combinations are contraindicated — your doctor should not prescribe them together:
Posaconazole dramatically increases sirolimus blood levels. This can cause sirolimus toxicity, including kidney damage, high cholesterol, and dangerous drops in blood cell counts. This is particularly relevant for transplant patients who may take both drugs.
Posaconazole can raise ergot alkaloid levels, increasing the risk of ergotism — a dangerous condition that can cause severe vasoconstriction (blood vessel narrowing), potentially leading to gangrene of the extremities.
Atorvastatin (Lipitor), Lovastatin (Mevacor), and Simvastatin (Zocor) should not be taken with Posaconazole. Elevated statin levels significantly increase the risk of rhabdomyolysis — a serious condition where muscle tissue breaks down, potentially causing kidney failure. If you need a statin while on Posaconazole, your doctor can choose alternatives like Pravastatin or Rosuvastatin, which are less affected.
Pimozide (Orap), an antipsychotic, has its levels increased by Posaconazole. Elevated pimozide can cause dangerous QTc prolongation and cardiac arrhythmias.
Like pimozide, quinidine combined with Posaconazole increases the risk of QTc prolongation and potentially fatal heart rhythms.
These drugs can be used with Posaconazole, but your doctor will need to monitor levels closely and likely reduce doses:
Posaconazole increases tacrolimus levels significantly. Since many patients on Posaconazole are also transplant recipients taking tacrolimus, this interaction is extremely common in clinical practice. Your doctor will reduce your tacrolimus dose (often by one-third to one-half) and monitor blood levels closely.
Similar to tacrolimus, Posaconazole increases cyclosporine levels. Dose reduction and careful monitoring of cyclosporine trough levels, kidney function, and blood pressure are required.
Posaconazole increases midazolam levels approximately 5-fold. This causes excessive and prolonged sedation. If benzodiazepines are needed, your doctor should choose ones less affected by CYP3A4 or significantly reduce the dose and monitor you closely.
For cancer patients receiving chemotherapy, Posaconazole can increase levels of vincristine and related drugs, raising the risk of neurotoxicity (nerve damage). Symptoms include numbness, tingling, weakness, and constipation. Your oncologist should be aware of this interaction.
These drugs can make Posaconazole less effective, potentially putting you at risk for fungal infection breakthrough:
Rifabutin (commonly used for mycobacterial infections) significantly decreases Posaconazole levels while Posaconazole increases rifabutin levels. This double problem makes the combination particularly tricky. Avoid if possible.
Phenytoin decreases Posaconazole levels, potentially reducing its antifungal effectiveness. If you need an anticonvulsant, discuss alternatives with your doctor.
This HIV medication significantly reduces Posaconazole blood levels. Alternative antiretroviral regimens should be considered when Posaconazole is necessary.
PPIs (like Omeprazole, Pantoprazole) and H2 blockers (like Famotidine) can reduce Posaconazole absorption. The delayed-release tablets are less affected than the old oral suspension, but the interaction still exists. If you take acid-reducing medication, mention it to your doctor — they may need to check your Posaconazole blood levels.
Posaconazole can prolong the QTc interval on an EKG. When combined with other QTc-prolonging medications, the risk of dangerous heart rhythm problems increases. Common QTc-prolonging drugs to watch for include:
Your doctor should review your complete medication list for QTc risk before starting Posaconazole. An EKG at baseline and during treatment helps monitor for changes. See our side effects guide for more on heart-related concerns.
Before your doctor prescribes Posaconazole, make sure they know about:
Bring a complete medication list to every appointment. If you start or stop any medication while taking Posaconazole, inform your prescriber and pharmacist.
Some common over-the-counter products can interact with Posaconazole:
Posaconazole is a life-saving medication, but its role as a strong CYP3A4 inhibitor means it interacts with a significant number of other drugs. Some combinations are outright dangerous; others require dose adjustments and monitoring. The key is complete transparency with your healthcare team about every medication, supplement, and over-the-counter product you use.
For more about Posaconazole, read our guides on how it works, side effects to watch for, and finding a doctor who prescribes it.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.